Associations Between Metabolic Obesity Phenotypes and Pathological Characteristics of Papillary Thyroid Carcinoma

被引:0
|
作者
Li, Xiuyun [1 ]
Zhang, Xiujuan [2 ]
Sun, Li [1 ,3 ]
Yang, Lulu [1 ]
Li, Qihang [4 ]
Wang, Zhixiang [1 ]
Wu, Yafei [1 ]
Gao, Ling [1 ,5 ]
Zhao, Jiajun [1 ]
Guo, Qingling [1 ]
Zhou, Meng [1 ]
机构
[1] Shandong First Med Univ, Shandong Prov Hosp, Key Lab Endocrine Glucose & Lipids Metab & Brain A, Minist Educ,Dept Endocrinol, Jingsi Rd 544, Jinan 250021, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Affiliated Hosp 1, Dept Endocrinol, Jinan, Shandong, Peoples R China
[4] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Endocrinol, Jinan, Shandong, Peoples R China
[5] Shandong First Med Univ, Shandong Prov Hosp, Key Lab, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
metabolic obesity phenotypes; papillary thyroid carcinoma; tumor size; multifocality; HDL-C; CANCER; MECHANISMS;
D O I
10.1016/j.eprac.2024.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The association between obesity, metabolic dysregulation, and the aggressive pathological traits of papillary thyroid carcinoma (PTC) continues to be a contentious issue. To date, no investigations have examined the impact of metabolic status on the malignant pathological features of PTC in relation to obesity. Methods: This research involved 855 adult patients with PTC from Shandong Provincial Hospital, classi fied into 4 groups based on metabolic and obesity status: metabolically healthy nonobese, metabolically unhealthy nonobese (MUNO), metabolically healthy obese, and metabolically unhealthy obese. We employed logistic regression to investigate the relationship between these metabolic obesity phenotypes and PTC's pathological characteristics. Mediation analysis was also performed to determine metabolic abnormalities' mediating role in the nexus between obesity and these characteristics. Results: Relative to metabolically healthy nonobese individuals, the metabolically unhealthy obese group was signi ficantly associated with an elevated risk of larger tumor sizes and a greater number of tumor foci in PTC. Mediation analysis indicated that obesity directly in fluences tumor size, whereas its effect on tumor multifocality is mediated through metabolic dysfunctions. Speci fically, highdensity lipoprotein cholesterol levels were notably associated with tumor multifocality within obese subjects, serving as a mediator in obesity's impact on this trait. Conclusion: The concurrent presence of obesity and metabolic dysregulation is often connected to more aggressive pathological features in PTC. The mediation analysis suggests obesity directly affects tumor size and indirectly in fluences tumor multifocality via low high-density lipoprotein cholesterol levels. (c) 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:624 / 630
页数:7
相关论文
共 50 条
  • [31] Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma
    Kwon, Hyemi
    Kim, Mijin
    Choi, Yun Mi
    Jang, Eun Kyung
    Jeon, Min Ji
    Kim, Won Gu
    Kim, Tae Yong
    Shong, Young Kee
    Song, Dong Eun
    Baek, Jung Hwan
    Hong, Suck Joon
    Kim, Won Bae
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (03) : 305 - 311
  • [32] Comparative pathological characteristics of papillary thyroid carcinoma with second primary non-thyroid malignancies in the region affected by the Chernobyl accident
    Fridman, Mikhail
    Krasko, Olga
    Levin, Leonid
    Veyalkin, Ilya
    Lam, Alfred King-Yin
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 228
  • [33] Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma
    Peng, Xuyang
    Zhu, Xi
    Cheng, Feng
    Zhou, Bin
    Zhu, Xiaohua
    Zhu, Lei
    GLAND SURGERY, 2020, 9 (04) : 950 - 955
  • [34] Comparison of clinicopathological characteristics and prognosis between primary squamous cell carcinoma of the thyroid and squamous cell carcinoma combined with papillary thyroid carcinoma
    Yan, Wanyun
    Chen, Huiying
    Lin, Xiaoyu
    Zhou, Ruifa
    Zhao, Feng
    Su, Jiping
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [35] Association between pathological variants of papillary thyroid cancer and prognosis
    Iribarren B, Osvaldo
    Madariaga G, Juan
    Zaffiri M, Vitorio
    Huidobro M, Patricio
    Mertens P, Maximiliano
    Iribarren R, Gabriel
    REVISTA CHILENA DE CIRUGIA, 2010, 62 (03): : 228 - 233
  • [36] Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review
    Chruscik, Anna
    Lam, Alfred King-yin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 99 (03) : 393 - 398
  • [37] PAPILLARY CARCINOMA OF THYROID - CLINICAL + PATHOLOGICAL STUDY OF 70 FATAL CASES
    TOLLEFSEN, HR
    HUTTER, RVP
    DECOSSE, JJ
    CANCER, 1964, 17 (08) : 1035 - &
  • [38] Follicular variant of papillary thyroid carcinoma: Clinico pathological study at SKMCH
    Sadaf, S.
    Akhtar, N.
    Mushtaq, S.
    Loya, A.
    Hassan, U.
    Hussain, M.
    Hayee, A.
    VIRCHOWS ARCHIV, 2016, 469 : S72 - S72
  • [39] Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia
    Stanojevic, Boban
    Dzodic, Radan
    Saenko, Vladimir
    Milovanovic, Zorka
    Pupic, Gordana
    Zivkovic, Ognjen
    Markovic, Ivan
    Djurisic, Igor
    Buta, Marko
    Dimitrijevic, Bogomir
    Rogounovitch, Tatiana
    Mitsutake, Norisato
    Mine, Mariko
    Shibata, Yoshisada
    Nakashima, Masahiro
    Yamashita, Shunichi
    ENDOCRINE JOURNAL, 2011, 58 (05) : 381 - 393
  • [40] Associations between metabolic overweight/obesity phenotypes and mortality risk among patients with chronic heart failure
    Zhou, You
    Xie, Yingli
    Dong, Jingjing
    He, Kunlun
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15